Lung Cancer and KRAS G12C Mutation (Factoid)
| Title: | Lung Cancer and KRAS G12C Mutation (Factoid) |
|---|---|
| Description: | Approximately 13% of people with lung cancer have a KRAS G12C mutation. Sotorasib is a new FDA-approved drug that targets this mutation. |
| Topics/Categories: |
Cancer Types -- Lung Cancer Infographics -- Health |
| Type: | Color, Illustration (JPEG format) |
| Source: | National Cancer Institute (NCI) |
| Date Created: | November 2022 |
| Date Added: | December 14, 2022 |
| Reuse Restrictions: | None - This image is in the public domain and can be freely reused. Please credit the source and, where possible, the creator listed above. |